MSF’s recent survey, conducted in partnership with T1International, revealed that an overwhelming 82% of individuals with diabetes favour insulin pens over ... Eli Lilly, and Sanofi—who ...

The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a ... head of connected care for Lilly Diabetes. "Using the learnings from early adopters of Tempo, we look ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Lilly isn’t the first diabetes specialist to tap into Dexcom ... Roche’s diagnostics division – to develop connected insulin pens. “CGMs provide people with diabetes and their healthcare ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.

INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly ... insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the American ...

Mounjaro is a prescription medicine available as a pre-filled single-dose pen ... Lilly's investigational medicines such as orforglipron as a potential treatment for adults with type 2 diabetes ...

Orforglipron was discovered by Chugai Pharmaceutical Co., Ltd. and licensed by Lilly in 2018 ... Do you take diabetes medicines, such as insulin or sulfonylureas? Do you have a history ...

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are transforming India's health landscape. But without strong oversight, risks may out ...